Anthem’s revenues totaled $29.3 billion in the second quarter of this year, up 14.9 percent year over year. Anthem attributed revenue growth in part to the launch of its pharmacy unit, IngenioRx, and higher premium revenue from increased growth in its Medicare and Medicaid lines.
The insurer’s expenses grew 8.8 percent year over year to $26.1 billion. Still, Anthem ended the quarter with a $2.3 billion profit, more than double the $1.1 billion the insurer posted in the same period a year prior. Reduced healthcare benefit use during the COVID-19 pandemic is part of the reason that Anthem said its profit grew.
Anthem said it has provided $2.5 billion in financial assistance to ease the burden of the COVID-19 pandemic for providers and members.
More articles on payers:
Anthem agrees to pay $27K medical bill after TV report airs
Leapfrog Group: Employers rank Cigna highest, UnitedHealthcare lowest on drive for value
Clover Health to triple footprint, expand coverage to 8 states
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
